The U.S. Food and Drug Administration (FDA) has recorded the methotrexate sodium injection (product number 001) from sponsor Quad Pharms as discontinued.
The product is an injectable formulation with a strength of EQ 25 mg base per mL. It is not designated as a reference drug, and its marketing status is listed as discontinued under application number ANDA089309.
Cập nhật pháp chế30 thg 8, 2026•1 phút đọc
FDA Discontinues Methotrexate Sodium Injection (ANDA089309)
The FDA has listed Quad Pharms' methotrexate sodium injection (product 001) as discontinued under ANDA089309.
Tổng hợp bởi đội ngũ PharmaCountry · Nguồn: FDA.gov
Đánh giá
(0)
(0)
(0)
(0)
(0)
Bài viết khác
Xem tất cả bài viếtNghiên cứu & Báo cáo
Global Finished Dosage Manufacturing Landscape 2026
5 thg 10, 2026
Cập nhật pháp chếKorea Korus hit with 1‑month manufacturing suspension over missing post‑marketing safety test
28 thg 9, 2026
Phân tíchPharma distributors set delivery cut‑offs ahead of Chuseok holiday (Sep 21‑23)
28 thg 9, 2026
Để lại đánh giá